Following President Obama's call for "precision medicine," the FDA has launched precisionFDA. The initiative is an online, cloud-based portal designed to foster collaboration between multiple stakeholders in industry, academia and government. The initiative "provides a publicly accessible online portal that enables community members to conduct genome analyses for comparison against reference material, then publish the results for review," explains the Personalized Medicine Coalition, which lauded the initiative to generate knowledge for future regulatory decisions. The launch commenced with the kickoff of an initial open beta version of the portal. More from the FDA's blog | Here's reaction from the Personalized Medicine Coalition